Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium in Advanced NSCLC
NCT07149649Phase 3Recruiting
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Sep 2026
- Primary completion
- Jan 2031
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium in non-small cell lung cancer (NSCLC), sponsored by Swiss Group for Clinical Cancer Research. Started Sep 2026; status: recruiting.
02
Drugs
magnesium
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07149649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07149649.